Mimetic sea cucumber-shaped nanoscale metal-organic frameworks composite for enhanced photodynamic therapy
Source abstract
Abstract
Abstract Therapeutic resistance caused by hypoxia tumor microenvironment (TME) is one of the main challenges for the development of nanoscale delivery systems, particular for the photodynamic agents. In this work, porphyrin-based metal-organic frameworks composite ACF@PCN-222@MnO2-PEG (APM) with the mimetic sea cucumber morphology was post-synthesized for using in photodynamic therapy (PDT) against hypoxia. Besides the good colloidal stability, as-synthesized APM nanoparticles also exhibited the well biocompatibility and H2O2-triggered drug releasing. After being reacted with endogenous H2O2, the amorphous MnO2 layer on the APM outersurface could quickly decompose to produce abundant oxygen, self-compensating for the consumption of photodynamic process. Meanwhile, the highly loaded hypoxia inhibitors acriflavine (ACF) of 18.7 wt% in APM was released to down-regulate the expression level of hypoxia-inducible factors (HIF). Combining with the self-generating oxygen and ACF inhibitors, the tumor hypoxia could be greatly relieved and the better tumor suppression effect by PDT have been demonstrated in vivo. This self-suppling oxygen nanosystem triggered by endogenous tumor markers proves a feasible way for remodeling the hypoxia TME and to achieve better therapeutic performances.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Cancer, Hypoxia, and Metabolism · Echinoderm biology and ecology
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (55)
Show source-provided references
1. Hypoxia - a key regulatory factor in tumour growth10.1038/nrc704 ↗
2. Overexpression of hypoxia-inducible factor 1 alpha in common human cancers and their metastases
3. Role of hypoxia in cancer therapy by regulating the tumor microenvironment10.1186/s12943-019-1089-9 ↗
4. Exploiting the cancer niche: tumor-associated macrophages and hypoxia as promising synergistic targets for nano-based therapy10.1016/j.jconrel.2017.03.013 ↗
5. mRNA-to-protein translation in hypoxia10.1186/s12943-019-0968-4 ↗
6. Advanced nanomaterials for hypoxia tumor therapy: challenges and solutions10.1039/D0NR06271E ↗
7. Improving cancer therapy through the nanomaterials-assisted alleviation of hypoxia10.1016/j.biomaterials.2019.119578 ↗
8. Nanoscale metal-organic framework overcomes hypoxia for photodynamic therapy primed cancer immunotherapy10.1021/jacs.8b01072 ↗
9. Self-generating oxygen enhanced mitochondrion-targeted photodynamic therapy for tumor treatment with hypoxia scavenging10.7150/thno.36988 ↗
10. O2-generating MnO2 nanoparticles for enhanced photodynamic therapy of bladder cancer by ameliorating hypoxia10.7150/thno.22465 ↗
11. Fluorinated polymeric micelles to overcome hypoxia and enhance photodynamic cancer therapy10.1039/C8BM00852C ↗
12. Overcoming the Achilles' heel of photodynamic therapy10.1039/C6CS00616G ↗
13. Metal-organic frameworks for photodynamic therapy: emerging synergistic cancer therapy10.1002/biot.201900382 ↗
14. Metal–organic Framework@Porous organic polymer nanocomposite for photodynamic therapy10.1021/acs.chemmater.7b00228 ↗
15. Incorporation of porphyrin to pi-conjugated backbone for polymer-dot-sensitized photodynamic therapy10.1021/acs.biomac.6b00356 ↗
16. Targeted intracellular delivery of photosensitizers to enhance photodynamic efficiency10.1046/j.1440-1711.2000.00925.x ↗
17. Nanomaterials to relieve tumor hypoxia for enhanced photodynamic therapy10.1016/j.nantod.2020.100960 ↗
18. Mycosporine glycine protects biological systems against photodynamic damage by quenching singlet oxygen with a high efficiency10.1562/0031-8655(2003)078<0109:MGPBSA>2.0.CO;2 ↗
19. Recent advances in strategies for overcoming hypoxia in photodynamic therapy of cancer10.1016/j.canlet.2020.07.007 ↗
20. Integration of metal-organic framework with a photoactive porous-organic polymer for interface enhanced phototherapy10.1016/j.biomaterials.2020.119792 ↗
21. Enhancing the efficacy of photodynamic therapy through a porphyrin/POSS alternating copolymer10.1002/anie.201808811 ↗
22. Cyclodextrin dimers as cleavable carriers of photodynamic sensitizers10.1021/ja011709o ↗
23. Smart strategies to overcome tumor hypoxia toward the enhancement of cancer therapy10.1039/D0NR05501H ↗
24. Tumor microenvironment activable self-assembled DNA hybrids for pH and redox dual-responsive chemotherapy/PDT treatment of hepatocellular carcinoma10.1002/advs.201600460 ↗
25. Nitroreductase-activatable theranostic molecules with high PDT efficiency under mild hypoxia based on a TADF fluorescein derivative10.1021/acsami.9b04488 ↗
26. Metal-organic frameworks: functional luminescent and photonic materials for sensing applications10.1039/C6CS00930A ↗
27. Hard-templated metal–organic frameworks for advanced applications10.1039/C9CS00813F ↗
28. Systematic tuning of the luminescence output of multicomponent metal-organic frameworks10.1021/jacs.8b09887 ↗
29. Catalysis and photocatalysis by metal organic frameworks10.1039/C8CS00256H ↗
30. Direct conversion of metal organic frameworks into ultrafine phosphide nanocomposites in multicomponent plasma for wide pH hydrogen evolution10.1039/D0TA02768E ↗
31. Biocatalytic metal‐organic framework‐based artificial cells10.1002/adfm.201905321 ↗
32. Zirconium-based nanoscale metal-organic framework/poly(epsilon-caprolactone) mixed-matrix membranes as effective antimicrobials10.1021/acsami.7b15826 ↗
33. Metal-organic frameworks: a future toolbox for biomedicine?10.1039/D0CS00883D ↗
34. Metal-organic framework nanoparticles in photodynamic therapy: current status and perspectives10.1002/adfm.201606314 ↗
35. BODIPY-containing nanoscale metal-organic frameworks for photodynamic therapy10.1039/C6CC01048B ↗
36. Nanoscale metal–organic frameworks for drug delivery: a conventional platform with new promise10.1039/C7TB02970E ↗
37. Toward an efficient photosensitizer for photodynamic therapy: incorporating BODIPY into porphyrinic nanoscale MOFs through the solvent-assisted ligand incorporation10.1016/j.dyepig.2019.107576 ↗
38. Structural diversity of nanoscale zirconium porphyrin MOFs and their photoactivities and biological performances10.1039/D1TB01311D ↗
39. Nanoscale mixed-component metal–organic frameworks with photosensitizer spatial-arrangement-dependent photochemistry for multimodal-imaging-guided photothermal therapy10.1021/acs.chemmater.8b03043 ↗
40. Biomimetic metal-organic framework nanoparticles for cooperative combination of antiangiogenesis and photodynamic therapy for enhanced efficacy10.1002/adma.201808200 ↗
41. Hypoxia-triggered nanoscale metal–organic frameworks for enhanced anticancer activity10.1021/acsami.8b07570 ↗
42. MnO2 gatekeeper: an intelligent and O2-evolving shell for preventing premature release of high cargo payload core, overcoming tumor hypoxia, and acidic H2O2-sensitive MRI10.1002/adfm.201604258 ↗
43. Azoreductase-responsive metal-organic framework-based nanodrug for enhanced cancer therapy via breaking hypoxia-induced chemoresistance10.1021/acsami.9b08115 ↗
44. Zirconium-metalloporphyrin PCN-222: mesoporous metal-organic frameworks with ultrahigh stability as biomimetic catalysts10.1002/anie.201204475 ↗
45. Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization10.1073/pnas.0909353106 ↗
46. HIF-1 alpha- targeting acriflavine provides long term survival and radiological tumor response in brain cancer therapy10.1038/s41598-017-14990-w ↗
47. Oxygen vacancy-enhanced photothermal performance and reactive oxygen species generation for synergistic tumour therapy10.1039/D0CC02536D ↗
48. Self-quenching synthesis of coordination polymer pre-drug nanoparticles for selective photodynamic therapy10.1039/C9TB01937E ↗
49. A nanoscale metal–organic framework to mediate photodynamic therapy and deliver CpG oligodeoxynucleotides to enhance antigen presentation and cancer immunotherapy10.1002/anie.201911429 ↗
50. Facile synthesis of uniform virus-like mesoporous silica nanoparticles for enhanced cellular internalization10.1021/acscentsci.7b00257 ↗
51. Stiffness-dependent in vitro uptake and lysosomal acidification of colloidal particles10.1002/anie.201409693 ↗
52. Deformable hollow periodic mesoporous organosilica nanocapsules for significantly improved cellular uptake10.1021/jacs.7b10694 ↗
53. Tumor oxygenation and hypoxia inducible factor-1 functional inhibition via a reactive oxygen species responsive nanoplatform for enhancing radiation therapy and abscopal effects10.1021/acsnano.8b03590 ↗
54. NADPH oxidase-mediated reactive oxygen species production activates hypoxia-inducible factor-1 (HIF-1) via the ERK pathway after hyperthermia treatment10.1073/pnas.1006646107 ↗
55. Targeting of HIF-α to the von Hippel-lindau ubiquitylation complex by O2-regulated prolyl hydroxylation10.1126/science.1059796 ↗